What is AKAN stock price today?

AKAN (Akanda Corp) stock is trading at $3.12 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is AKAN stock going up or down today?

AKAN stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy AKAN stock now?

The decision to buy AKAN depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is AKAN a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for AKAN based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is AKAN stock overvalued or undervalued?

AKAN currently trades at a P/E ratio of 0.00, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if AKAN is fairly priced.

What is AKAN's P/E ratio?

AKAN has a price-to-earnings (P/E) ratio of 0.00, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is AKAN's market cap?

AKAN (Akanda Corp) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is AKAN's price to book ratio?

AKAN trades at a price-to-book (P/B) ratio of 0.51, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does AKAN pay dividends?

AKAN does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is AKAN's dividend yield?

AKAN does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is AKAN stock a good long-term investment?

AKAN's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is AKAN's revenue growth rate?

AKAN has shown revenue growth of 0.2% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

AKAN is currently operating at a loss. Some companies prioritize growth over profitability in early stages. Review our financial analysis for detailed insights.

What are the risks of investing in AKAN?

Key risks for AKAN include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does AKAN compare to its competitors?

Compare AKAN to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize AKAN's performance and positioning.

What is AKAN's stock price target for 2026?

Our AI model provides price targets for AKAN based on fundamental analysis: Bull case $4.06 (+30%), Base case $3.59 (+15%), Bear case $2.81 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about AKAN?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for AKAN. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is AKAN's next earnings report?

AKAN reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

AKAN - Akanda Corp

NYSE * Health Care * Pharmaceuticals

$3.12

$-0.01 (-0.32%)

About Akanda Corp

As of August 21, 2025, Akanda Corp. was acquired by First Towers & Fiber Corp., in a reverse merger transaction. Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis-based products. The company was incorporated in 2021 and is headquartered in Toronto, Canada.

AKAN Key Statistics

Market Cap

$1.67M

P/E Ratio

0.00

P/B Ratio

0.51

EPS

$696.80

Revenue Growth

+0.2%

Profit Margin

-2.7%

How AKAN Compares to Peers

AKAN has the lowest P/E ratio in Pharmaceuticals, suggesting it may be the most undervalued

AKAN has the fastest revenue growth among competitors

AKAN is the smallest among peers, which may offer higher growth potential

P/E Rank

of 2

Margin Rank

of 2

Growth Rank

of 2

Size Rank

of 2

Company	Market Cap	P/E	Growth	Margin	Compare
AKAN(This stock)	$1.67M	0.0	0%	-2.7%	-
AMZNAmazon Com	$2.68T	34.7	0%	0.1%	vs AMZN

Akanda Corp Company Information

Headquarters: United Kingdom
Website: www.akandacorp.com
Sector: Health Care
Industry: Pharmaceuticals

Data Updated: April 15, 2026 at 4:34 PM EDT

Ready to invest in AKAN?

Commission-free trading available. Affiliate links.

Upcoming Events for AKAN

Dashboard

Enter a ticker to analyze